Novartis unit laid out reasons why FDA wasn't told of data scandal sooner

Novartis unit laid out reasons why FDA wasn't told of data scandal sooner

STAT Plus: Novartis unit says FDA wasn’t told of data manipulation sooner because it was ‘highly complex’

By ED SILVERMAN

RUBY WALLAU FOR STAT

The Novartis unit at the center of the data scandal offered copious details about the efforts to recount actions taken after learning about the problems.

READ MORE